BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lurie Y, Webb M, Cytter-Kuint R, Shteingart S, Lederkremer GZ. Non-invasive diagnosis of liver fibrosis and cirrhosis. World J Gastroenterol 2015; 21(41): 11567-11583 [PMID: 26556987 DOI: 10.3748/wjg.v21.i41.11567] [Cited by in CrossRef: 120] [Cited by in F6Publishing: 105] [Article Influence: 17.1] [Reference Citation Analysis]
Number Citing Articles
1 Ranucci G, Rigoldi M, Cotugno G, Bernabei SM, Liguori A, Gasperini S, Goffredo BM, Martinelli D, Monti L, Francalanci P, Candusso M, Parini R, Dionisi‐vici C. Chronic liver involvement in urea cycle disorders. Jrnl of Inher Metab Disea 2019;42:1118-27. [DOI: 10.1002/jimd.12144] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
2 Abbas SH, Pickett E, Lomas DA, Thorburn D, Gooptu B, Hurst JR, Marshall A. Non-invasive testing for liver pathology in alpha-1 antitrypsin deficiency. BMJ Open Respir Res 2020;7:e000820. [PMID: 33323365 DOI: 10.1136/bmjresp-2020-000820] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Yang T, Fu Z, Zhang Y, Wang M, Mao C, Ge W. Serum proteomics analysis of candidate predictive biomarker panel for the diagnosis of trastuzumab-based therapy resistant breast cancer. Biomed Pharmacother 2020;129:110465. [PMID: 32887021 DOI: 10.1016/j.biopha.2020.110465] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Lin CY, Lin CC, Wang CC, Chen CL, Hu TH, Hung CH, Huang PY, Tsai MC. The ALBI Grade is a Good Predictive Model for Very Late Recurrence in Patients with Hepatocellular Carcinoma Undergoing Primary Resection. World J Surg. 2020;44:247-257. [PMID: 31559485 DOI: 10.1007/s00268-019-05197-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Toia GV, Mileto A, Wang CL, Sahani DV. Quantitative dual-energy CT techniques in the abdomen. Abdom Radiol (NY) 2021. [PMID: 34468796 DOI: 10.1007/s00261-021-03266-7] [Reference Citation Analysis]
6 Chambal LM, Gudo ES, Carimo A, Corte Real R, Mabunda N, Maueia C, Vubil A, Zicai AF, Bhatt N, Antunes F. HBV infection in untreated HIV-infected adults in Maputo, Mozambique. PLoS One 2017;12:e0181836. [PMID: 28759595 DOI: 10.1371/journal.pone.0181836] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
7 Mehta KJ, Farnaud SJ, Sharp PA. Iron and liver fibrosis: Mechanistic and clinical aspects. World J Gastroenterol 2019; 25(5): 521-538 [PMID: 30774269 DOI: 10.3748/wjg.v25.i5.521] [Cited by in CrossRef: 58] [Cited by in F6Publishing: 52] [Article Influence: 19.3] [Reference Citation Analysis]
8 Takata R, Nishikawa H, Enomoto H, Iwata Y, Ishii A, Miyamoto Y, Ishii N, Yuri Y, Hasegawa K, Nakano C, Nishimura T, Yoh K, Aizawa N, Sakai Y, Ikeda N, Takashima T, Iijima H, Nishiguchi S. Relationship between skeletal muscle mass and liver fibrosis markers for patients with hepatitis C virus related liver disease. Medicine (Baltimore) 2017;96:e8761. [PMID: 29310350 DOI: 10.1097/MD.0000000000008761] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
9 Hong YS, Chang Y, Ryu S, Cainzos-Achirica M, Kwon MJ, Zhang Y, Choi Y, Ahn J, Rampal S, Zhao D, Pastor-Barriuso R, Lazo M, Shin H, Cho J, Guallar E. Hepatitis B and C virus infection and diabetes mellitus: A cohort study. Sci Rep 2017;7:4606. [PMID: 28676706 DOI: 10.1038/s41598-017-04206-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
10 Giuffrè M, Fouraki S, Comar M, Masutti F, Crocè LS. The Importance of Transaminases Flare in Liver Elastography: Characterization of the Probability of Liver Fibrosis Overestimation by Hepatitis C Virus-Induced Cytolysis. Microorganisms 2020;8:E348. [PMID: 32121404 DOI: 10.3390/microorganisms8030348] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 9.5] [Reference Citation Analysis]
11 Besheer T, Arafa M, El-Maksoud MA, Elalfy H, Hasson A, Zalata K, Elkashef W, Elshahawy H, Raafat D, Elemshaty W, Elsayed E, Zaghloul H, Razek AA, El-Bendary M. Diagnosis of cirrhosis in patients with chronic hepatitis C genotype 4: Role of ABCB11 genotype polymorphism and plasma bile acid levels. Turk J Gastroenterol 2018;29:299-307. [PMID: 29755014 DOI: 10.5152/tjg.2018.17570] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
12 Toriguchi K, Miyashita S, Kawabata Y, Kurimoto A, Okuno M, Iwama H, Iida K, Okamoto T, Sueoka H, Tada M, Nakamura I, Fujimoto Y, Nishimura T, Iijima H, Hatano E. Liver stiffness measured by virtual touch quantification predicts the occurrence of posthepatectomy refractory ascites in patients with hepatocellular carcinoma. Surg Today 2021. [PMID: 34708306 DOI: 10.1007/s00595-021-02392-5] [Reference Citation Analysis]
13 Catanzaro R, Sciuto M, Lanzafame C, Balakrishnan B, Marotta F. Platelet to lymphocyte ratio as a predictive biomarker of liver fibrosis (on elastography) in patients with hepatitis C virus (HCV)-related liver disease. Indian J Gastroenterol 2020;39:253-60. [PMID: 32833144 DOI: 10.1007/s12664-020-01038-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Anwar M, Jamal Q, Ahmed W. Liver histology in asymptomatic Hepatitis-C virus positive blood donors. Pak J Med Sci 2018;34:100-5. [PMID: 29643887 DOI: 10.12669/pjms.341.14361] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Yang T, Xu P, Gu L, Xu Z, Ge W, Li Q, Xu F. Quantitative assessment of serum heat shock protein 27 for the diagnosis of epithelial ovarian cancer using targeted proteomics coupled with immunoaffinity enrichment. Clin Chim Acta 2019;489:96-102. [PMID: 30502327 DOI: 10.1016/j.cca.2018.11.032] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
16 Si-Mohamed S, Tatard-Leitman V, Laugerette A, Sigovan M, Pfeiffer D, Rummeny EJ, Coulon P, Yagil Y, Douek P, Boussel L, Noël PB. Spectral Photon-Counting Computed Tomography (SPCCT): in-vivo single-acquisition multi-phase liver imaging with a dual contrast agent protocol. Sci Rep 2019;9:8458. [PMID: 31186467 DOI: 10.1038/s41598-019-44821-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
17 Perez I, Bolte FJ, Bigelow W, Dickson Z, Shah NL. Step by Step: Managing the Complications of Cirrhosis. Hepat Med 2021;13:45-57. [PMID: 34079394 DOI: 10.2147/HMER.S278032] [Reference Citation Analysis]
18 Zhou J, Deng Y, Yan L, Zhao H, Wang G; China HepB-Related Fibrosis Assessment Research Group. Serum platelet-derived growth factor BB levels: a potential biomarker for the assessment of liver fibrosis in patients with chronic hepatitis B. Int J Infect Dis 2016;49:94-9. [PMID: 27292607 DOI: 10.1016/j.ijid.2016.06.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
19 Lin E, Zou B, Zeng G, Cai C, Li P, Chen J, Li D, Zhang B, Li J. The impact of liver fibrosis on microvascular invasion and prognosis of hepatocellular carcinoma with a solitary nodule: a Surveillance, Epidemiology, and End Results (SEER) database analysis. Ann Transl Med 2021;9:1310. [PMID: 34532447 DOI: 10.21037/atm-21-3731] [Reference Citation Analysis]
20 Singh A, Gosai F, Siddiqui MT, Gupta M, Lopez R, Lawitz E, Poordad F, Carey W, McCullough A, Alkhouri N. Accuracy of Noninvasive Fibrosis Scores to Detect Advanced Fibrosis in Patients With Type-2 Diabetes With Biopsy-proven Nonalcoholic Fatty Liver Disease. J Clin Gastroenterol 2020;54:891-7. [PMID: 32168133 DOI: 10.1097/MCG.0000000000001339] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
21 Wang SH, Du J, Xu H, Yang D, Ye Y, Chen Y, Zhu Y, Ba T, Yuan C, Yang ZH. Automatic discrimination of different sequences and phases of liver MRI using a dense feature fusion neural network: a preliminary study. Abdom Radiol (NY) 2021;46:4576-87. [PMID: 34057565 DOI: 10.1007/s00261-021-03142-4] [Reference Citation Analysis]
22 Xin Z, Wu X, Ji T, Xu B, Han Y, Sun M, Jiang S, Li T, Hu W, Deng C, Yang Y. Bakuchiol: A newly discovered warrior against organ damage. Pharmacological Research 2019;141:208-13. [DOI: 10.1016/j.phrs.2019.01.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
23 Wu S, Meng X, Jiang X, Wu Y, Zhai S, Wang X, Liu Y, Zhang J, Zhao X, Zhou Y, Bu W, Yao Z. Harnessing X-Ray Energy-Dependent Attenuation of Bismuth-Based Nanoprobes for Accurate Diagnosis of Liver Fibrosis. Adv Sci (Weinh) 2021;8:e2002548. [PMID: 34105274 DOI: 10.1002/advs.202002548] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Wang Y, Chen B, Xiao C, Yu J, Bu X, Jiang F, Ding W, Ge Z. Effect of miR-183-5p on Cholestatic Liver Fibrosis by Regulating Fork Head Box Protein O1 Expression. Front Physiol 2021;12:737313. [PMID: 34867446 DOI: 10.3389/fphys.2021.737313] [Reference Citation Analysis]
25 Hou ZB, Zhao F, Zhang B, Zhang CZ. Study on clinical application of susceptibility weighted imaging ombined with diffusion weighted imaging in patients with Liver Cirrhosis complicated with small Hepatocellular Carcinoma. Pak J Med Sci 2021;37:800-4. [PMID: 34104168 DOI: 10.12669/pjms.37.3.3822] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Moon CM, Shin SS, Heo SH, Lim HS, Moon MJ, Surendran SP, Kim GE, Park IW, Jeong YY. Metabolic Changes in Different Stages of Liver Fibrosis: In vivo Hyperpolarized 13C MR Spectroscopy and Metabolic Imaging. Mol Imaging Biol 2019;21:842-51. [PMID: 30693432 DOI: 10.1007/s11307-019-01322-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
27 Egerman RS. New Antiviral Agents for Treatment of Hepatitis C. Clin Obstet Gynecol 2019;62:823-34. [PMID: 31094712 DOI: 10.1097/GRF.0000000000000457] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Shiha G, Soliman R, Mikhail NNH, Alswat K, Abdo A, Sanai F, Derbala MF, Örmeci N, Dalekos GN, Al-Busafi S, Hamoudi W, Sharara AI, Zaky S, El-Raey F, Mabrouk M, Marzouk S, Toyoda H. Development and multicenter validation of FIB-6: A novel, machine learning, simple bedside score to rule out liver cirrhosis and compensated advanced chronic liver disease in patients with chronic hepatitis C. Hepatol Res 2021. [PMID: 34767312 DOI: 10.1111/hepr.13729] [Reference Citation Analysis]
29 Fang H, Yu L, You D, Peng N, Guo W, Wang J, Zhang X. In vivo Therapeutic Effects and Mechanisms of Hydroxyasiaticoside Combined With Praziquantel in the Treatment of Schistosomiasis Induced Hepatic Fibrosis. Front Bioeng Biotechnol 2020;8:613784. [PMID: 33553120 DOI: 10.3389/fbioe.2020.613784] [Reference Citation Analysis]
30 Li X, Liu H, Wang R, Yang J, Zhang Y, Li C. Gadoxetate-disodium-enhanced magnetic resonance imaging for liver fibrosis staging: a systematic review and meta-analysis. Clin Radiol 2020;75:319.e11-9. [PMID: 31831141 DOI: 10.1016/j.crad.2019.11.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Liao J, Zhang Z, Yuan Q, Liu Q, Kuang J, Fang Y, Hu X. A lncRNA Gpr137b-ps/miR-200a-3p/CXCL14 axis modulates hepatic stellate cell (HSC) activation. Toxicol Lett 2021;336:21-31. [PMID: 33069761 DOI: 10.1016/j.toxlet.2020.10.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
32 Fujita K, Masaki T. Serum Biomarkers of Liver Fibrosis Staging in the Era of the Concept "Compensated Advanced Chronic Liver Disease". J Clin Med 2021;10:3340. [PMID: 34362121 DOI: 10.3390/jcm10153340] [Reference Citation Analysis]
33 El-Gohary M, Moore M, Roderick P, Watkins E, Dash J, Reinson T, Newell C, Kim M, Stuart B, Becque T, Sheron N. Local care and treatment of liver disease (LOCATE) - A cluster-randomized feasibility study to discover, assess and manage early liver disease in primary care. PLoS One 2018;13:e0208798. [PMID: 30576330 DOI: 10.1371/journal.pone.0208798] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
34 Nishikawa H, Yoh K, Enomoto H, Iwata Y, Sakai Y, Kishino K, Shimono Y, Ikeda N, Takashima T, Aizawa N, Takata R, Hasegawa K, Koriyama T, Yuri Y, Nishimura T, Nishiguchi S, Iijima H. Serum Zinc Level Is Associated with Frailty in Chronic Liver Diseases. J Clin Med 2020;9:E1570. [PMID: 32455875 DOI: 10.3390/jcm9051570] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
35 Abd El-Wahab EW, Metwally M, Lotfy N. Effectiveness of hepatitis B vaccination in chronic HCV patients after successful generic direct acting antiviral therapy: significance of isolated hepatitis B core antibodies. Trop Med Int Health 2021;26:882-94. [PMID: 33860608 DOI: 10.1111/tmi.13588] [Reference Citation Analysis]
36 Cano A, Mariño Z, Millet O, Martínez-Arranz I, Navasa M, Falcón-Pérez JM, Pérez-Cormenzana M, Caballería J, Embade N, Forns X, Bosch J, Castro A, Mato JM. A Metabolomics Signature Linked To Liver Fibrosis In The Serum Of Transplanted Hepatitis C Patients. Sci Rep 2017;7:10497. [PMID: 28874799 DOI: 10.1038/s41598-017-10807-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
37 Roccarina D, Iogna Prat L, Buzzetti E, Guerrero Misas M, Aricó FM, Saffioti F, Rosselli M, Pinzani M, Marshall A, Thorburn D, Tsochatzis E. Establishing Reliability Criteria for Liver ElastPQ Shear Wave Elastography (ElastPQ-SWE): Comparison Between 10, 5 and 3 Measurements. Ultraschall Med 2021;42:204-13. [PMID: 31594008 DOI: 10.1055/a-1010-6052] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Anger F, Klein I, Löb S, Wiegering A, Singh G, Sperl D, Götze O, Geier A, Lock JF. Preoperative Liver Function Guiding HCC Resection in Normal and Cirrhotic Liver. Visc Med 2021;37:94-101. [PMID: 33977098 DOI: 10.1159/000508172] [Reference Citation Analysis]
39 Ziff J, Vu T, Dvir D, Riazi F, Toribio W, Oster S, Sigel K, Weiss J. Predictors of hepatitis C treatment outcomes in a harm reduction-focused primary care program in New York City. Harm Reduct J 2021;18:38. [PMID: 33789691 DOI: 10.1186/s12954-021-00486-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Young S, Rivard M, Kimyon R, Sanghvi T. Accuracy of liver ablation zone prediction in a single 2450 MHz 100 Watt generator model microwave ablation system: An in human study. Diagnostic and Interventional Imaging 2020;101:225-33. [DOI: 10.1016/j.diii.2019.10.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Argalia G, Tarantino G, Ventura C, Campioni D, Tagliati C, Guardati P, Kostandini A, Marzioni M, Giuseppetti GM, Giovagnoni A. Shear wave elastography and transient elastography in HCV patients after direct-acting antivirals. Radiol Med 2021;126:894-9. [PMID: 33492651 DOI: 10.1007/s11547-020-01326-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
42 Wang XP, Wang Y, Ma H, Wang H, Yang DW, Zhao XY, Jin EH, Yang ZH. Assessment of liver fibrosis with liver and spleen magnetic resonance elastography, serum markers in chronic liver disease. Quant Imaging Med Surg 2020;10:1208-22. [PMID: 32550131 DOI: 10.21037/qims-19-849] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
43 Fan C, Wu FR, Zhang JF, Jiang H. A Network Pharmacology Approach to Explore the Mechanisms of Shugan Jianpi Formula in Liver Fibrosis. Evid Based Complement Alternat Med 2020;2020:4780383. [PMID: 32617108 DOI: 10.1155/2020/4780383] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
44 Poilil Surendran S, George Thomas R, Moon MJ, Jeong YY. Nanoparticles for the treatment of liver fibrosis. Int J Nanomedicine. 2017;12:6997-7006. [PMID: 29033567 DOI: 10.2147/ijn.s145951] [Cited by in Crossref: 37] [Cited by in F6Publishing: 22] [Article Influence: 7.4] [Reference Citation Analysis]
45 Maepa MB, Ely A, Arbuthnot P. How successful has targeted RNA interference for hepatic fibrosis been? Expert Opin Biol Ther 2018;18:381-8. [PMID: 29265946 DOI: 10.1080/14712598.2018.1420775] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
46 Haghgoo SM, Sharafi H, Alavian SM. Serum cytokines, adipokines and ferritin for non-invasive assessment of liver fibrosis in chronic liver disease: a systematic review. Clin Chem Lab Med 2019;57:577-610. [PMID: 30231008 DOI: 10.1515/cclm-2018-0357] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
47 Zhao Y, Wu J, Zhang Q, Hua Z, Qi W, Wang N, Lin T, Sheng L, Cui D, Liu J, Song Q, Li X, Wu T, Guo Y, Cui J, Liu A. Radiomics Analysis Based on Multiparametric MRI for Predicting Early Recurrence in Hepatocellular Carcinoma After Partial Hepatectomy. J Magn Reson Imaging. 2020;. [PMID: 33217114 DOI: 10.1002/jmri.27424] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
48 He D, Zhang C, Qiu W, Xie Q. Diagnosis of liver fibrosis in patients with hepatitis B-related liver disease using ultrasound with wave-number domain attenuation coefficient. Turk J Gastroenterol 2020;31:923-9. [PMID: 33626006 DOI: 10.5152/tjg.2020.20139] [Reference Citation Analysis]
49 Wang D, Zhan X, Wu R, You Y, Chen W, Duan L. Assessment of Pyroptosis-Related Indicators as Potential Biomarkers and Their Association with Severity in Patients with Liver Cirrhosis. J Inflamm Res 2021;14:3185-96. [PMID: 34285542 DOI: 10.2147/JIR.S319213] [Reference Citation Analysis]
50 Li Y, Ma J, Li B, Zhu X, Wang J. Cirrhosis of Wilson's disease: High and low cutoff using acoustic radiation force impulse (ARFI) -Comparison and combination with serum fibrosis index. Clin Hemorheol Microcirc 2021. [PMID: 34334385 DOI: 10.3233/CH-211219] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Neuberger J, Cain O. The Need for Alternatives to Liver Biopsies: Non-Invasive Analytics and Diagnostics. Hepat Med 2021;13:59-69. [PMID: 34163263 DOI: 10.2147/HMER.S278076] [Reference Citation Analysis]
52 Saleh SA, Salama MM, Alhusseini MM, Mohamed GA. M2BPGi for assessing liver fibrosis in patients with hepatitis C treated with direct-acting antivirals. World J Gastroenterol 2020; 26(21): 2864-2876 [PMID: 32550761 DOI: 10.3748/wjg.v26.i21.2864] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Li Q, Li H, Lv Y, Zhang Q, Zhang X, Li S, Zheng X, Wang Y, Hao Z. Hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein (HIP/PAP) confers protection against hepatic fibrosis through downregulation of transforming growth factor β receptor II. Lab Invest 2020;100:466-82. [PMID: 31641222 DOI: 10.1038/s41374-019-0314-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
54 Yang JD, Heimbach JK. New advances in the diagnosis and management of hepatocellular carcinoma. BMJ. [DOI: 10.1136/bmj.m3544] [Cited by in Crossref: 13] [Cited by in F6Publishing: 26] [Article Influence: 6.5] [Reference Citation Analysis]
55 Owojuyigbe OS, Larbie C, Firempong CK, Komlaga G, Emikpe BO, Oyagbemi AA. Hura crepitans stem bark extract: A potential remedy to sub-acute liver damage. J Ethnopharmacol 2021;284:114768. [PMID: 34688802 DOI: 10.1016/j.jep.2021.114768] [Reference Citation Analysis]
56 Nishikawa H, Yoh K, Enomoto H, Iwata Y, Sakai Y, Kishino K, Shimono Y, Ikeda N, Takashima T, Aizawa N, Takata R, Hasegawa K, Koriyama T, Yuri Y, Nishimura T, Nishiguchi S, Iijima H. Calf Circumference as a Useful Predictor of Sarcopenia in Patients With Liver Diseases. In Vivo. 2020;34:2561-2569. [PMID: 32871785 DOI: 10.21873/invivo.12073] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
57 Zhang Y, Zhang Y, Liang H, Zhuo Z, Fan P, Chen Y, Zhang Z, Zhang W. Serum N-terminal DDR1: A Novel Diagnostic Marker of Liver Fibrosis Severity. J Clin Transl Hepatol 2021;9:702-10. [PMID: 34722185 DOI: 10.14218/JCTH.2021.00024] [Reference Citation Analysis]
58 Dawood RM, El-Meguid MA, Ibrahim MK, Bader El Din NG, Barakat A, El-Wakeel K, Alla MDAA, Wu GY, El Awady MK. Dysregulation of fibrosis related genes in HCV induced liver disease. Gene 2018;664:58-69. [PMID: 29684485 DOI: 10.1016/j.gene.2018.04.032] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
59 Syed T, Chadha N, Kumar D, Gupta G, Sterling RK. Non-Invasive Assessment of Liver Fibrosis and Steatosis in End-Stage Renal Disease Patients Undergoing Renal Transplant Evaluation. Gastroenterology Res 2021;14:244-51. [PMID: 34527094 DOI: 10.14740/gr1445] [Reference Citation Analysis]
60 Laroia ST, Vellore Srinivasan S, Yadav K, Rastogi A, Kumar S, Kumar G, Kumar M. Performance of shear wave elastography: A single centre pilot study of mixed etiology liver disease patients with normal BMI. Australas J Ultrasound Med 2021;24:120-36. [PMID: 34765422 DOI: 10.1002/ajum.12244] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Caruso M, Cuocolo R, Di Dato F, Mollica C, Vallone G, Romeo V, Petretta M, Liuzzi R, Mainenti PP, Iorio R, Brunetti A, Maurea S. Ultrasound, shear-wave elastography, and magnetic resonance imaging in native liver survivor patients with biliary atresia after Kasai portoenterostomy: correlation with medical outcome after treatment. Acta Radiol 2020;61:1300-8. [PMID: 32008344 DOI: 10.1177/0284185120902379] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
62 da Silva Franco KMV, Vieira WB, Dias ARN, Falcão ASC, Falcão LFM, Quaresma JAS. Doppler ultrasonography: A non-invasive method used to diagnose and follow up patients with chronic hepatitis C. J Gastroenterol Hepatol 2020;35:314-9. [PMID: 31335991 DOI: 10.1111/jgh.14793] [Reference Citation Analysis]
63 Toson EA, Shiha GE, Abdelgaleel AE. Fibrogenic/Angiogenic Linker for Non-Invasive Assessment of Hepatic Fibrosis Staging in Chronic Hepatitis C Among Egyptian Patients. Ann Hepatol 2017;16:862-73. [PMID: 29055924 DOI: 10.5604/01.3001.0010.5276] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
64 Martínez-Castillo M, Rosique-Oramas D, Medina-Avila Z, Pérez-Hernández JL, Higuera-De la Tijera F, Santana-Vargas D, Montalvo-Jave EE, Sanchez-Avila F, Torre A, Kershenobich D, Gutierrez-Reyes G. Differential production of insulin-like growth factor-binding proteins in liver fibrosis progression. Mol Cell Biochem 2020;469:65-75. [PMID: 32301061 DOI: 10.1007/s11010-020-03728-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
65 Shimizu T, Aoki T, Park KH, Matsumoto T, Shiraki T, Sakuraoka Y, Mori S, Iso Y, Ishizuka M, Kubota K. Volumetric assessment and clinical predictors of cirrhosis in patients undergoing hepatectomy for hepatocellular carcinoma with presumed normal liver function. Hepatol Int 2021;15:1258-67. [PMID: 34426889 DOI: 10.1007/s12072-021-10246-y] [Reference Citation Analysis]
66 Wu S, Tseng Y, Xu N, Yin X, Xie X, Zhang L, Wu W, Zhu W, Wu W, Yao J, Wu Y. Evaluation of transient elastography in assessing liver fibrosis in patients with advanced schistosomiasis japonica. Parasitol Int 2018;67:302-8. [PMID: 29355611 DOI: 10.1016/j.parint.2018.01.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
67 Peveler WJ, Landis RF, Yazdani M, Day JW, Modi R, Carmalt CJ, Rosenberg WM, Rotello VM. A Rapid and Robust Diagnostic for Liver Fibrosis Using a Multichannel Polymer Sensor Array. Adv Mater 2018;30:e1800634. [PMID: 29797373 DOI: 10.1002/adma.201800634] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 7.3] [Reference Citation Analysis]
68 Pershina AG, Ivanov VV, Efimova LV, Shevelev OB, Vtorushin SV, Perevozchikova TV, Sazonov AE, Ogorodova LM. Magnetic resonance imaging and spectroscopy for differential assessment of liver abnormalities induced by Opisthorchis felineus in an animal model. PLoS Negl Trop Dis 2017;11:e0005778. [PMID: 28708894 DOI: 10.1371/journal.pntd.0005778] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
69 Atsukawa M, Tsubota A, Kondo C, Uchida-Kobayashi S, Takaguchi K, Tsutsui A, Nozaki A, Chuma M, Hidaka I, Ishikawa T, Iwasa M, Tamai Y, Tobari M, Matsuura K, Nagura Y, Abe H, Kato K, Suzuki K, Okubo T, Arai T, Itokawa N, Toyoda H, Enomoto M, Tamori A, Tanaka Y, Kawada N, Takei Y, Iwakiri K. A novel noninvasive formula for predicting cirrhosis in patients with chronic hepatitis C. PLoS One 2021;16:e0257166. [PMID: 34506563 DOI: 10.1371/journal.pone.0257166] [Reference Citation Analysis]
70 Tay A, Albayrak F, Ozmen S, Albayrak A, Ozden K. Is Serum Angiotensin-Converting Enzyme Level Useful For Determining Necroinflammatory Activity In Chronic Hepatitis B Infection? Genet Test Mol Biomarkers. 2017;21:102-107. [PMID: 28207324 DOI: 10.1089/gtmb.2016.0067] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
71 Chandel R, Saxena R, Das A, Kaur J. Association of rno‐miR‐183‐96‐182 cluster with diethyinitrosamine induced liver fibrosis in Wistar rats. J Cell Biochem 2018;119:4072-84. [DOI: 10.1002/jcb.26583] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
72 Durot I, Akhbardeh A, Sagreiya H, Loening AM, Rubin DL. A New Multimodel Machine Learning Framework to Improve Hepatic Fibrosis Grading Using Ultrasound Elastography Systems from Different Vendors. Ultrasound Med Biol 2020;46:26-33. [PMID: 31611074 DOI: 10.1016/j.ultrasmedbio.2019.09.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
73 Serag WM, Mohamed MM, Elsayed BE, Abd-Elhamed SM. Determination of liver fibrosis stages in Egyptian chronic hepatitis B patients by a noninvasive tool. Turk J Med Sci 2019;49:1145-50. [PMID: 31385666 DOI: 10.3906/sag-1812-165] [Reference Citation Analysis]
74 Tana C, Tana M, Rossi S, Silingardi M, Schiavone C. Hepatic artery resistive index (HARI) and non-alcoholic fatty liver disease (NAFLD) fibrosis score in NAFLD patients: cut-off suggestive of non-alcoholic steatohepatitis (NASH) evolution. J Ultrasound 2016;19:183-9. [PMID: 27635163 DOI: 10.1007/s40477-016-0203-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
75 Li F, Li Q, Liu Y, Han J, Zheng W, Huang Y, Zheng X, Cao L, Zhou J. Distinguishing intrahepatic cholangiocarcinoma from hepatocellular carcinoma in patients with and without risks: the evaluation of the LR-M criteria of contrast-enhanced ultrasound liver imaging reporting and data system version 2017. Eur Radiol 2020;30:461-70. [DOI: 10.1007/s00330-019-06317-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
76 Zentner D, Celermajer DS, Gentles T, d’Udekem Y, Ayer J, Blue GM, Bridgman C, Burchill L, Cheung M, Cordina R, Culnane E, Davis A, du Plessis K, Eagleson K, Finucane K, Frank B, Greenway S, Grigg L, Hardikar W, Hornung T, Hynson J, Iyengar AJ, James P, Justo R, Kalman J, Kasparian N, Le B, Marshall K, Mathew J, Mcgiffin D, Mcguire M, Monagle P, Moore B, Neilsen J, O’connor B, O’donnell C, Pflaumer A, Rice K, Sholler G, Skinner JR, Sood S, Ward J, Weintraub R, Wilson T, Wilson W, Winlaw D, Wood A. Management of People With a Fontan Circulation: a Cardiac Society of Australia and New Zealand Position statement. Heart, Lung and Circulation 2020;29:5-39. [DOI: 10.1016/j.hlc.2019.09.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
77 Nishikawa H, Yoh K, Enomoto H, Iwata Y, Sakai Y, Kishino K, Shimono Y, Ikeda N, Takashima T, Aizawa N, Takata R, Hasegawa K, Koriyama T, Yuri Y, Nishimura T, Nishiguchi S, Iijima H. Sarcopenia and Frailty in Chronic Liver Damage: Common and Different Points. In Vivo 2020;34:2549-59. [PMID: 32871784 DOI: 10.21873/invivo.12072] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
78 Korda D, Lenard ZM, Gerlei Z, Jakab Z, Haboub-Sandil A, Wagner L, Varga M, Cseprekal O, Marton A, Horvathy D, Takacs S, Doros A, Mathe Z. Shear-wave elastography for the assessment of liver fibrosis in liver transplant recipients treated for hepatitis C virus recurrence. Eur J Gastroenterol Hepatol 2018;30:27-32. [PMID: 29049126 DOI: 10.1097/MEG.0000000000001003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 3.8] [Reference Citation Analysis]
79 Pinato DJ, Sharma R, Allara E, Yen C, Arizumi T, Kubota K, Bettinger D, Jang JW, Smirne C, Kim YW, Kudo M, Howell J, Ramaswami R, Burlone ME, Guerra V, Thimme R, Ishizuka M, Stebbing J, Pirisi M, Carr BI. The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma. Journal of Hepatology 2017;66:338-46. [DOI: 10.1016/j.jhep.2016.09.008] [Cited by in Crossref: 144] [Cited by in F6Publishing: 142] [Article Influence: 28.8] [Reference Citation Analysis]
80 Yu H, Touret A, Li B, O'brien M, Qureshi MM, Soto JA, Jara H, Anderson SW. Application of texture analysis on parametric T1 and T2 maps for detection of hepatic fibrosis: Texture Analysis on Parametric T1 and T2. J Magn Reson Imaging 2017;45:250-9. [DOI: 10.1002/jmri.25328] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
81 Bassetti M, Peghin M, Carnelutti A, Righi E, Merelli M, Ansaldi F, Trucchi C, Alicino C, Sartor A, Toniutto P, Wauters J, Laleman W, Tascini C, Menichetti F, Luzzati R, Brugnaro P, Mesini A, Raviolo S, De Rosa FG, Lagunes L, Rello J, Dimopoulos G, Colombo AL, Nucci M, Vena A, Bouza E, Muñoz P, Tumbarello M, Losito R, Martin-loeches I, Viscoli C. Clinical characteristics and predictors of mortality in cirrhotic patients with candidemia and intra-abdominal candidiasis: a multicenter study. Intensive Care Med 2017;43:509-18. [DOI: 10.1007/s00134-017-4717-0] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 5.8] [Reference Citation Analysis]
82 Xie C, Ma B, Wang N, Wan L. Comparison of serological assessments in the diagnosis of liver fibrosis in bile duct ligation mice. Exp Biol Med (Maywood) 2017;242:1398-404. [PMID: 28669222 DOI: 10.1177/1535370217718179] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
83 Wang X, Wu B. Critical issues in the diagnosis and treatment of liver cirrhosis. Gastroenterol Rep (Oxf) 2019;7:227-30. [PMID: 31413829 DOI: 10.1093/gastro/goz024] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
84 Akiyama MJ, Agyemang L, Arnsten JH, Heo M, Norton BL, Schackman BR, Linas BP, Litwin AH. Rationale, design, and methodology of a trial evaluating three models of care for HCV treatment among injection drug users on opioid agonist therapy. BMC Infect Dis 2018;18:74. [PMID: 29426304 DOI: 10.1186/s12879-018-2964-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
85 Caruso M, Ricciardi C, Delli Paoli G, Di Dato F, Donisi L, Romeo V, Petretta M, Iorio R, Cesarelli G, Brunetti A, Maurea S. Machine Learning Evaluation of Biliary Atresia Patients to Predict Long-Term Outcome after the Kasai Procedure. Bioengineering (Basel) 2021;8:152. [PMID: 34821718 DOI: 10.3390/bioengineering8110152] [Reference Citation Analysis]
86 Chang Y, Kim JI, Lee B, Kim SG, Jung MJ, Kim YS, Jeong SW, Jang JY, Yoo JJ. Clinical application of ultrasonography-guided percutaneous liver biopsy and its safety over 18 years. Clin Mol Hepatol 2020;26:318-27. [PMID: 32447878 DOI: 10.3350/cmh.2019.0019n] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
87 Gong X, Wang X, Zhou F. Liver microRNA-29b-3p positively correlates with relative enhancement values of magnetic resonance imaging and represses liver fibrosis. J Biochem 2020;168:603-9. [PMID: 32653922 DOI: 10.1093/jb/mvaa074] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
88 Jonas MC, Loftus B, Horberg MA. The Road to Hepatitis C Virus Cure: Practical Considerations from a Health System's Perspective. Infect Dis Clin North Am 2018;32:481-93. [PMID: 29778267 DOI: 10.1016/j.idc.2018.02.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
89 Feng LM, Lei SJ, Zeng X, Wang PQ, Chen RT, Wang J, Sheng X, Shi PM, Yuan ZL, Xie WF. The evaluation of non-invasive multi-slice spiral computed tomography-based indices for the diagnosis and prognosis prediction of liver cirrhosis. J Dig Dis 2017;18:472-9. [PMID: 28671764 DOI: 10.1111/1751-2980.12506] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
90 Xiao H, Shi M, Xie Y, Chi X. Comparison of diagnostic accuracy of magnetic resonance elastography and Fibroscan for detecting liver fibrosis in chronic hepatitis B patients: A systematic review and meta-analysis. PLoS One 2017;12:e0186660. [PMID: 29107943 DOI: 10.1371/journal.pone.0186660] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 6.4] [Reference Citation Analysis]
91 Chang Y, Han JA, Kang SM, Jeong SW, Ryu T, Park HS, Yoo JJ, Lee SH, Kim SG, Kim YS, Kim HS, Jin SY, Ryu S, Jang JY. Clinical impact of serum exosomal microRNA in liver fibrosis. PLoS One 2021;16:e0255672. [PMID: 34506494 DOI: 10.1371/journal.pone.0255672] [Reference Citation Analysis]
92 Dong S, Cai FF, Chen QL, Song YN, Sun Y, Wei B, Li XY, Hu YY, Liu P, Su SB. Chinese herbal formula Fuzheng Huayu alleviates CCl4-induced liver fibrosis in rats: a transcriptomic and proteomic analysis. Acta Pharmacol Sin 2018;39:930-41. [PMID: 29094729 DOI: 10.1038/aps.2017.150] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
93 Pfeifer L, Adler W, Zopf S, Siebler J, Wildner D, Goertz RS, Schellhaas B, Neurath MF, Strobel D. Acoustic radiation force impulse elastography: comparison and combination with other noninvasive tests for the diagnosis of compensated liver cirrhosis. European Journal of Gastroenterology & Hepatology 2017;29:524-30. [DOI: 10.1097/meg.0000000000000827] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
94 Yin Y, Yakar D, Dierckx RAJO, Mouridsen KB, Kwee TC, de Haas RJ. Liver fibrosis staging by deep learning: a visual-based explanation of diagnostic decisions of the model. Eur Radiol 2021. [PMID: 34014382 DOI: 10.1007/s00330-021-08046-x] [Reference Citation Analysis]
95 Ajao S, Roach D, Chan KH, Thimmanagari K, Muhanna A, Mutyala M, Lakasanni S, Slim J. The Roles of Fibrosis Index Based on Four Factors and Aspartate Transaminase-to-Platelet Ratio Index Scoring Systems as an Alternative to Transient Elastography Liver Stiffness in Liver Fibrosis Staging in Human Immunodeficiency Virus and Hepatitis C Virus Co-Infected Patients. Gastroenterology Res 2021;14:209-13. [PMID: 34527089 DOI: 10.14740/gr1377] [Reference Citation Analysis]
96 Casler K, Trees K, Bosak K. Providing Care for Fatty Liver Disease Patients: Primary Care Nurse Practitioners' Knowledge, Actions, and Preparedness. Gastroenterol Nurs 2020;43:E184-9. [PMID: 32889968 DOI: 10.1097/SGA.0000000000000487] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
97 Pawlowska M, Sobolewska-Pilarczyk M, Domagalski K. Hepatitis C virus infection in children in the era of direct-acting antiviral. World J Gastroenterol 2018; 24(24): 2555-2566 [PMID: 29962813 DOI: 10.3748/wjg.v24.i24.2555] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
98 Shirabe K, Bekki Y, Gantumur D, Araki K, Ishii N, Kuno A, Narimatsu H, Mizokami M. Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis. J Gastroenterol 2018;53:819-26. [PMID: 29318378 DOI: 10.1007/s00535-017-1425-z] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 14.3] [Reference Citation Analysis]
99 Lagoutte P, Bettler E, Vadon-Le Goff S, Moali C. Procollagen C-proteinase enhancer-1 (PCPE-1), a potential biomarker and therapeutic target for fibrosis. Matrix Biol Plus 2021;11:100062. [PMID: 34435180 DOI: 10.1016/j.mbplus.2021.100062] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
100 Hu J, Li P, Song Y, Ge YX, Meng XM, Huang C, Li J, Xu T. Progress and prospects of circular RNAs in Hepatocellular carcinoma: Novel insights into their function. J Cell Physiol. 2018;233:4408-4422. [PMID: 28833094 DOI: 10.1002/jcp.26154] [Cited by in Crossref: 30] [Cited by in F6Publishing: 36] [Article Influence: 6.0] [Reference Citation Analysis]
101 Cao R, Zhang S, Li J, Zhang J, Zhao Y, Jiao P, Wang C, Guo Z. Chinese Herbal Medicine-Induced Rapid Liver Cirrhosis: A Case Report. Hepat Mon 2021;21. [DOI: 10.5812/hepatmon.118934] [Reference Citation Analysis]
102 Du J, Shi J, Liu J, Deng C, Shen J, Wang Q. Hemodynamic analysis of hepatic arteries for the early evaluation of hepatic fibrosis in biliary atresia. Comput Methods Programs Biomed 2021;211:106400. [PMID: 34551379 DOI: 10.1016/j.cmpb.2021.106400] [Reference Citation Analysis]
103 Nishikawa H, Yoh K, Enomoto H, Ikeda N, Aizawa N, Koriyama T, Nishimura T, Nishiguchi S, Iijima H. Anthropometric Measurements and Frailty in Patients with Liver Diseases. Diagnostics (Basel). 2020;10:433. [PMID: 32630551 DOI: 10.3390/diagnostics10060433] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
104 Peng W, Cheng S, Bao Z, Wang Y, Zhou W, Wang J, Yang Q, Chen C, Wang W. Advances in the research of nanodrug delivery system for targeted treatment of liver fibrosis. Biomedicine & Pharmacotherapy 2021;137:111342. [DOI: 10.1016/j.biopha.2021.111342] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
105 Lee T, Teng TZJ, Shelat VG. Carbohydrate antigen 19-9 — tumor marker: Past, present, and future. World J Gastrointest Surg 2020; 12(12): 468-490 [PMID: 33437400 DOI: 10.4240/wjgs.v12.i12.468] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 9] [Article Influence: 7.5] [Reference Citation Analysis]
106 Llovet LP, Gratacós-Ginès J, Téllez L, Gómez-Outomuro A, Navascués CA, Riveiro-Barciela M, Vinuesa R, Gómez-Camarero J, García-Retortillo M, Díaz-Fontenla F, Salcedo M, García-Eliz M, Horta D, Guerrero M, Rodríguez-Perálvarez M, Fernández-Rodriguez C, Albillos A, G-Abraldes J, Parés A, Londoño MC. Noninvasive Prediction of Outcomes in Autoimmune Hepatitis-Related Cirrhosis. Hepatol Commun 2022. [PMID: 34989164 DOI: 10.1002/hep4.1889] [Reference Citation Analysis]
107 Mo YH, Chen HL, Hsu WM, Chang CH, Peng SS. A noninvasive index to predict liver cirrhosis in biliary atresia. Pediatr Radiol 2021;51:257-64. [PMID: 32964265 DOI: 10.1007/s00247-020-04823-w] [Reference Citation Analysis]
108 Durot I, Akhbardeh A, Rosenberg J, Willmann JK. Point Shear Wave Elastography for Grading Liver Fibrosis: Can the Number of Measurements Be Reduced? Ultrasound Med Biol 2018;44:2569-77. [PMID: 30224172 DOI: 10.1016/j.ultrasmedbio.2018.07.028] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
109 Tseng CW, Chang TT, Tzeng SJ, Hsieh YH, Hung TH, Huang HT, Wu SF, Tseng KC. Association of sustained virologic response with reduced progression to liver cirrhosis in elderly patients with chronic hepatitis C. Clin Interv Aging 2016;11:327-34. [PMID: 27051280 DOI: 10.2147/CIA.S97242] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
110 Shin GM, Koppula S, Chae YJ, Kim HS, Lee JD, Kim MK, Song M. Anti-hepatofibrosis effect of Allium senescens in activated hepatic stellate cells and thioacetamide-induced fibrosis rat model. Pharm Biol 2018;56:632-42. [PMID: 31070527 DOI: 10.1080/13880209.2018.1529801] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
111 Nishikawa H, Nishimura T, Enomoto H, Iwata Y, Ishii A, Miyamoto Y, Ishii N, Yuri Y, Takata R, Hasegawa K, Nakano C, Yoh K, Aizawa N, Sakai Y, Ikeda N, Takashima T, Nishiguchi S, Iijima H. Impact of Virtual Touch Quantification in Acoustic Radiation Force Impulse for Skeletal Muscle Mass Loss in Chronic Liver Diseases. Nutrients 2017;9:E620. [PMID: 28621757 DOI: 10.3390/nu9060620] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
112 Zachou K, Gabeta S, Shums Z, Gatselis NK, Koukoulis GK, Norman GL, Dalekos GN. COMP serum levels: A new non-invasive biomarker of liver fibrosis in patients with chronic viral hepatitis. Eur J Intern Med. 2017;38:83-88. [PMID: 28100410 DOI: 10.1016/j.ejim.2017.01.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
113 Behairy OG, El-Gendy SA, Ibrahim DY, Mansour AI, El-Shimi OS. Mac-2 binding protein glycan isomer as noninvasive tool to assess liver fibrosis in children with chronic liver disease. Hepatol Res 2021;51:277-83. [PMID: 33393720 DOI: 10.1111/hepr.13608] [Reference Citation Analysis]
114 Carimo AA, Gudo ES, Maueia C, Mabunda N, Chambal L, Vubil A, Flora A, Antunes F, Bhatt N. First report of occult hepatitis B infection among ART naïve HIV seropositive individuals in Maputo, Mozambique. PLoS One 2018;13:e0190775. [PMID: 29320552 DOI: 10.1371/journal.pone.0190775] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
115 Borro P, Ziola S, Pasta A, Trombini M, Labanca S, Marenco S, Solarna D, Pisciotta L, Baldissarro I, Picciotto A, Dellepiane S. Hepatic Elastometry and Glissonian Line in the Assessment of Liver Fibrosis. Ultrasound Med Biol 2021;47:947-59. [PMID: 33451815 DOI: 10.1016/j.ultrasmedbio.2020.12.015] [Reference Citation Analysis]
116 Messner CJ, Schmidt S, Özkul D, Gaiser C, Terracciano L, Krähenbühl S, Suter-Dick L. Identification of miR-199a-5p, miR-214-3p and miR-99b-5p as Fibrosis-Specific Extracellular Biomarkers and Promoters of HSC Activation. Int J Mol Sci 2021;22:9799. [PMID: 34575957 DOI: 10.3390/ijms22189799] [Reference Citation Analysis]
117 Catanzaro R, Aleo A, Sciuto M, Zanoli L, Balakrishnan B, Marotta F. FIB-4 and APRI scores for predicting severe liver fibrosis in chronic hepatitis HCV patients: a monocentric retrospective study. Clin Exp Hepatol 2021;7:111-6. [PMID: 34027123 DOI: 10.5114/ceh.2021.104543] [Reference Citation Analysis]
118 Hashem A, Awad A, Shousha H, Alakel W, Salama A, Awad T, Mabrouk M. Validation of a machine learning approach using FIB-4 and APRI scores assessed by the metavir scoring system: A cohort study. Arab J Gastroenterol 2021;22:88-92. [PMID: 33985905 DOI: 10.1016/j.ajg.2021.04.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]